Amid drama, Cutera tosses out CEO and chair, appoints replacements

Paul Schloesser

Associate Editor

A medtech company has terminated two of its top executives “for cause,” appointing an interim CEO amidst drama over company control and a substantial drop …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Amid drama, Cutera tosses out CEO and chair, appoints replacements

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Amid dra­ma, Cutera toss­es out CEO and chair, ap­points re­place­ments

Associate Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Amid drama, Cutera tosses out CEO and chair, appoints replacements